Clinical Trial Update: A Phase 1b Clinical Trial of 13-valent Pneumococcal Polysaccharide Conjugate Vaccine [Phase 1]

View source ↗

Summary

This is a Phase 1b clinical trial evaluating the safety and immunogenicity of a 13-valent pneumococcal polysaccharide conjugate vaccine (PCV13), which has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Disease

Drugs mentioned

• Prevnar 13 (pneumococcal conjugate vaccine)

Snippet

Sponsor: Sinovac Research and Development Co., Ltd. | Conditions: Pneumococcal Infectious Disease | Phase 1 | Status: COMPLETED